Neogen Corp. (NASDAQ:NEOG) CFO Steven J. Quinlan sold 3,000 shares of Neogen Corp. stock in a transaction dated Monday, November 14th. The stock was sold at an average price of $61.28, for a total value of $183,840.00. Following the completion of the transaction, the chief financial officer now directly owns 13,103 shares of the company’s stock, valued at $802,951.84. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Shares of Neogen Corp. (NASDAQ:NEOG) traded up 0.96% during mid-day trading on Thursday, reaching $61.00. The company had a trading volume of 125,062 shares. The firm has a 50-day moving average of $54.65 and a 200-day moving average of $54.50. Neogen Corp. has a 12-month low of $43.79 and a 12-month high of $62.55. The company has a market capitalization of $2300.25 billion, a P/E ratio of 61.62 and a beta of 1.50.

Neogen Corp. (NASDAQ:NEOG) last announced its earnings results on Tuesday, September 27th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.26. Neogen Corp. had a net margin of 11.25% and a return on equity of 9.36%. The company earned $83.65 million during the quarter. During the same quarter last year, the firm posted $0.25 earnings per share. The firm’s revenue was up 11.7% on a year-over-year basis. On average, equities analysts anticipate that Neogen Corp. will post $1.12 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Neogen Corp. (NASDAQ:NEOG)

A number of hedge funds have recently bought and sold shares of NEOG. Vanguard Group Inc. raised its stake in Neogen Corp. by 2.6% in the second quarter. Vanguard Group Inc. now owns 2,918,694 shares of the company’s stock valued at $164,176,000 after buying an additional 72,939 shares during the last quarter. BlackRock Fund Advisors raised its stake in Neogen Corp. by 7.8% in the third quarter. BlackRock Fund Advisors now owns 2,529,639 shares of the company’s stock valued at $141,508,000 after buying an additional 183,014 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in Neogen Corp. by 3.5% in the third quarter. PNC Financial Services Group Inc. now owns 1,200,388 shares of the company’s stock valued at $67,151,000 after buying an additional 40,451 shares during the last quarter. BlackRock Institutional Trust Company N.A. raised its stake in Neogen Corp. by 2.9% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 938,926 shares of the company’s stock valued at $52,524,000 after buying an additional 26,586 shares during the last quarter. Finally, Conestoga Capital Advisors LLC raised its stake in Neogen Corp. by 12.3% in the third quarter. Conestoga Capital Advisors LLC now owns 877,779 shares of the company’s stock valued at $49,103,000 after buying an additional 96,293 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Several research analysts have recently weighed in on the company. Zacks Investment Research lowered Neogen Corp. from a “hold” rating to a “sell” rating in a research report on Tuesday, October 11th. Craig Hallum lowered Neogen Corp. from a “buy” rating to a “hold” rating in a research report on Monday, August 29th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $58.25.

About Neogen Corp.

Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.

5 Day Chart for NASDAQ:NEOG

Receive News & Stock Ratings for Neogen Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen Corp. and related stocks with our FREE daily email newsletter.